Steven Madden
SHOO Nasdaq Footwear Financials FY2016βFY2025
Steven Madden's revenue rose 11.0% to $2.5 billion in fiscal 2025. Its operating margin was 3.2%, down from 9.8% a year earlier. Free cash flow was $120 million, down 30.6%. It paid out $74 million in dividends and buybacks, 62% of free cash flow. The diluted share count fell 1.1%.
What Steven Madden does
No business description yet.
- Legal name
- STEVEN MADDEN, LTD.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-012995
0000913241
Revenue and margins
Steven Madden had $2.5B of revenue in fiscal 2025, up 11.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β8.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $120M in fiscal 2025, 4.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Steven Madden returned $74.5M to shareholders in fiscal 2025, 62% of free cash flow. The diluted share count fell 1.1%.
Value Steven Madden yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$122M and divides by 71.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 21.6x Β· peers 11.2x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Steven Madden can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $264M | $290M | $220M | $203M | $112M |
| Debt incl. finance leases | β | β | β | $0.0M | $234M |
| Net debt / EBITDA | β | β | β | β0.8x | 1.1x |
| Debt / equity | β | β | β | 0.0x | 0.3x |
| Interest coverage | β | β | β | β | 6.9x |
| Current ratio | 2.2x | 2.6x | 2.3x | 2.2x | 1.9x |
| Quick ratio | 1.6x | 1.9x | 1.7x | 1.5x | 1.1x |
| Total assets | $1.4B | $1.3B | $1.3B | $1.4B | $1.9B |
| Total liabilities | $535M | $414M | $500M | $536M | $1.0B |
| Shareholders' equity | $812M | $832M | $830M | $848M | $866M |
| Net debt (β = net cash) | β | β | β | β$203M | $122M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$2.3M
7 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Amelia VarelaPresident, Director | Sold | 15,000 | $48.59 | $0.7M | Form 4 |
| Aug 5, 2026 | Arian Simone ReedDirector | Sold | 1,250 | $48.76 | $0.1M | Form 4 |
| Aug 5, 2026 | Mitchell S KlipperDirector | Sold | 3,918 | $48.54 | $0.2M | Form 4 |
| Aug 4, 2026 | Al FerraraDirector | Sold | 3,918 | $48.26 | $0.2M | Form 4 |
| Aug 4, 2026 | Peter Allan DavisDirector | Sold | 525 | $48.31 | $0.0M | Form 4 |
| Jun 15, 2026 | Arian Simone ReedDirector | Sold | 1,100 | $45.38 | $0.0M | Form 4 |
| Jun 15, 2026 | Peter MiglioriniDirector | Sold | 4,000 | $45.30 | $0.2M | Form 4 |
| Jun 9, 2026 | Christina CiglarChief Product Officer | Sold | 5,147 | $44.74 | $0.2M | Form 4 |
| Jun 4, 2026 | Arian Simone ReedDirector | Sold | 475 | $43.82 | $0.0M | Form 4 |
| Jun 3, 2026 | Amelia VarelaPresident, Director | Sold | 10,000 | $43.45 | $0.4M | Form 4 |
| May 22, 2026 | Peter Allan DavisDirector | Sold | 3,030 | $41.98 | $0.1M | Form 4 |
| May 20, 2026 | Arian Simone ReedDirector | Sold | 648 | $39.97 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | 6 / 9 |
| Accruals ratio | β4.2% | β1.6% | β6.8% |
| Altman Z'' | 9.23 | 9.15 | 5.87 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Steven Madden SHOO | $3.1B | 11.0% | 3.2% | 4.7% | 6.0% | 21.6x | 6 | |
| Wolverine World Wide WWW | $1.7B | 6.8% | 8.0% | 6.7% | 15.1% | 15.8x | 7 | Compare β |
| Crocs CROX | $5.9B | β1.5% | 3.7% | 16.3% | 2.8% | 10.4x | 5 | Compare β |
| Deckers Brands DECK | $11.2B | 9.8% | 23.1% | 20.1% | 160.4% | 11.5x | 4 | Compare β |
| Gentex GNTX | $4.3B | 9.6% | 18.7% | 18.1% | 17.4% | 10.9x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.4B | $1.6B | $1.7B | $1.8B | $1.2B | $1.9B | $2.1B | $2.0B | $2.3B | $2.5B |
| Gross profit | $522M | $599M | $640M | $686M | $465M | $768M | $874M | $832M | $937M | $1.0B |
| Operating income | $169M | $170M | $173M | $177M | β$31.6M | $244M | $282M | $213M | $225M | $80.8M |
| Interest expense | $0.2M | $0.0M | $0.0M | $0.0M | $0.4M | $0.0M | $0.0M | $0.0M | $0.0M | $11.7M |
| Pretax income | $171M | $172M | $177M | $181M | β$30.0M | $242M | $282M | $221M | $231M | $77.7M |
| Income tax | $49.7M | $53.2M | $46.8M | $39.5M | β$11.7M | $49.6M | $65.1M | $46.6M | $54.6M | $28.7M |
| Net income | $121M | $118M | $129M | $141M | β$18.4M | $193M | $217M | $174M | $176M | $49.0M |
| Diluted EPS | $1.35 | $1.36 | $1.50 | $1.69 | β$0.23 | $2.34 | $2.77 | $2.30 | $2.35 | $0.63 |
| Diluted shares | 0.09B | 0.09B | 0.09B | 0.08B | 0.08B | 0.08B | 0.08B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $154M | $158M | $154M | $234M | $44.2M | $160M | $268M | $229M | $198M | $162M |
| Capital expenditure | $15.9M | $14.8M | $12.4M | $18.3M | $6.6M | $6.6M | $16.4M | $19.5M | $25.9M | $42.7M |
| Free cash flow | $138M | $143M | $142M | $215M | $37.6M | $153M | $252M | $210M | $172M | $120M |
| Depreciation and amortization | $21.1M | $21.4M | $22.5M | $21.3M | $17.4M | $15.2M | $20.6M | $15.5M | $20.0M | $33.4M |
| Stock-based compensation | $19.5M | $20.8M | $21.1M | $23.2M | $22.6M | $22.3M | $24.4M | $24.1M | $26.5M | $29.6M |
| Acquisitions | $0.0M | $16.8M | $0.0M | $37.2M | $0.0M | $0.0M | $0.0M | $75.3M | $14.0M | $372M |
| Share buybacks | $86.0M | $99.4M | $106M | $102M | $46.6M | $123M | $149M | $142M | $98.4M | $13.5M |
| Dividends paid | $0.0M | $0.0M | $47.3M | $48.4M | $12.5M | $49.2M | $66.0M | $63.2M | $61.0M | $61.0M |
| Dividends and buybacks | $86.0M | $99.4M | $153M | $150M | $59.0M | $172M | $215M | $206M | $159M | $74.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $126M | $181M | $200M | $264M | $287M | $264M | $290M | $220M | $203M | $112M |
| Total debt | β | β | β | β | β | β | β | β | $0.0M | $234M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $529M | $646M | $703M | $719M | $698M | $945M | $844M | $855M | $895M | $1.0B |
| Current liabilities | $183M | $207M | $225M | $281M | $236M | $435M | $321M | $378M | $414M | $526M |
| Inventory | $120M | $110M | $137M | $137M | $101M | $255M | $229M | $229M | $258M | $417M |
| Property and equipment, net | $72.4M | $71.5M | $64.8M | $65.5M | $43.3M | $35.8M | $40.7M | $47.2M | $57.4M | $116M |
| Total assets | $961M | $1.1B | $1.1B | $1.3B | $1.1B | $1.4B | $1.3B | $1.3B | $1.4B | $1.9B |
| Total liabilities | $220M | $248M | $258M | $437M | $347M | $535M | $414M | $500M | $536M | $1.0B |
| Shareholders' equity | $741M | $803M | $806M | $829M | $777M | $812M | $832M | $830M | $848M | $866M |
| Margins | ||||||||||
| Gross margin | 37.3% | 38.2% | 38.2% | 38.4% | 38.7% | 41.1% | 41.2% | 42.0% | 41.0% | 41.4% |
| Operating margin | 12.1% | 10.8% | 10.3% | 9.9% | β2.6% | 13.1% | 13.3% | 10.8% | 9.9% | 3.2% |
| EBITDA margin | 13.6% | 12.2% | 11.7% | 11.1% | β1.2% | 13.9% | 14.2% | 11.5% | 10.7% | 4.5% |
| Net margin | 8.6% | 7.5% | 7.7% | 7.9% | β1.5% | 10.3% | 10.2% | 8.8% | 7.7% | 1.9% |
| FCF margin | 9.8% | 9.1% | 8.5% | 12.1% | 3.1% | 8.2% | 11.9% | 10.6% | 7.5% | 4.7% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | β | 6.0% |
| Return on capital employed | 22.3% | 20.9% | 20.4% | 19.2% | β3.3% | 26.7% | 30.3% | 22.4% | 22.9% | 6.8% |
| Return on equity | 17.0% | 15.3% | 16.1% | 17.3% | β2.3% | 24.2% | 26.4% | 21.0% | 21.0% | 5.7% |
| Return on assets | 12.9% | 11.7% | 12.1% | 12.0% | β1.5% | 15.4% | 16.6% | 13.4% | 12.8% | 3.0% |
| Growth | ||||||||||
| Revenue growth | β0.4% | 12.0% | 7.1% | 6.5% | β32.8% | 55.3% | 13.7% | β6.6% | 15.2% | 11.0% |
| Net income growth | 7.1% | β2.5% | 9.5% | 9.4% | β113.0% | β | 12.9% | β19.9% | 1.1% | β72.1% |
| EPS growth | 9.5% | 0.7% | 10.3% | 12.7% | β113.6% | β | 18.4% | β17.0% | 2.2% | β73.2% |
| FCF growth | 18.2% | 4.0% | β0.9% | 51.8% | β82.5% | 306.1% | 64.6% | β16.6% | β17.9% | β30.6% |
| Share count change | β2.6% | β2.9% | β0.8% | β2.9% | β6.0% | 3.8% | β4.4% | β4.5% | β3.5% | β1.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β | β0.8x | 1.1x |
| Debt / equity | β | β | β | β | β | β | β | β | 0.0x | 0.3x |
| Interest coverage | 762.1x | 7,074.3x | 4,816.2x | 7,072.6x | β89.3x | β | β | β | β | 6.9x |
| Current ratio | 2.9x | 3.1x | 3.1x | 2.6x | 3.0x | 2.2x | 2.6x | 2.3x | 2.2x | 1.9x |
| Quick ratio | 2.2x | 2.6x | 2.5x | 2.1x | 2.5x | 1.6x | 1.9x | 1.7x | 1.5x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 0.9% | 0.7% | 1.0% | 0.6% | 0.4% | 0.8% | 1.0% | 1.1% | 1.7% |
| Stock comp / revenue | 1.4% | 1.3% | 1.3% | 1.3% | 1.9% | 1.2% | 1.2% | 1.2% | 1.2% | 1.2% |
| Payouts / FCF | 62.5% | 69.4% | 108.0% | 69.7% | 156.8% | 112.7% | 85.4% | 98.0% | 92.6% | 62.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | β | β | β | β | 6.0 |
| Altman Z'' | 10.5 | 10.7 | 11.0 | 8.5 | 8.5 | 8.7 | 10.4 | 9.2 | 9.2 | 5.9 |
| Accruals ratio | β3.5% | β4.0% | β2.4% | β7.9% | β5.2% | 2.7% | β3.9% | β4.2% | β1.6% | β6.8% |
Source: SEC EDGAR XBRL filings (CIK 0000913241). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.